AMRI to Announce Fourth Quarter Results
ALBANY, N.Y., Jan. 15, 2013
ALBANY, N.Y., Jan. 15, 2013 /PRNewswire/ --AMRI (NASDAQ: AMRI) today
announced it will issue fourth quarter and full year financial results before
the opening of the market on Tuesday, February 12, 2013. Following the release
of its results, the company will host a conference call and simultaneous
webcast at 10 a.m. ET.
(Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO )
The conference call can be accessed by dialing 888-438-5535 (domestic calls)
or 719-325-2455 (international calls) at 9:50 a.m. ET and entering passcode
2539488. The webcast will be available live via the Internet and can be
accessed on the company's website at www.amriglobal.com. Replays of the
webcast can also be accessed for up to 90 days after the call via the investor
area of the company's website at www.amriglobal.com/investor_relations/.
Albany Molecular Research, Inc. (AMRI) is a global contract research and
manufacturing organization offering customers fully integrated drug discovery,
development, and manufacturing services. For over 21 years AMRI has
demonstrated its adaptability as the pharmaceutical and biotechnology
industries have undergone tremendous change in response to multiple
challenges. This experience, a track record of success and locations in the
United States, Europe and Asia now provides our customers with SMARTSOURCING™,
a full range of value-added opportunities providing customers informed
decision-making, enhanced efficiency and more successful outcomes at all
stages of the pipeline. AMRI has also successfully partnered R&D programs and
is actively seeking to out-license its remaining programs for further
development. For more information about AMRI, please visit our website at
www.amriglobal.com or follow us on Twitter (@amriglobal).
Contact: Investor - Michael Nolan, Chief Financial Officer, +1-518-512-2261;
Media - Gina Monari, AMRI Communications, +1-518-512-2512
Press spacebar to pause and continue. Press esc to stop.